𝔖 Bobbio Scriptorium

✦ LIBER ✦

A 4-week, randomized, double-blind, parallel group trial evaluating the efficacy and tolerability of sebum control product in male and female subjects with oily skin appearance and mild to moderate acne vulgaris

Book ID: 116582210
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 47 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.10.115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A twelve-week, multicenter, randomized,

A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH)

✍ Jose Luis Palma Gámiz; Mariano Pêgo; Emilio Márquez Contreras; Montserrat Pujol 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Evaluation of the Efficacy and Tolerabil

Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

✍ Hiromi Rakugi; Toshio Ogihara; Yuko Miyata; Kiyofumi Sasai; Nobuo Totsuka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Efficacy and tolerability of nebivolol m

Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension

✍ F. Wilford Germino 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB